Crit care med:机械通气患者早期镇静是否有益?

2017-12-15 MedSci MedSci原创

越来越多的数据表明,早期的深度镇静可能会对临床结果产生一定的负面影响。近期,一项发表在杂志Crit care med上的系统综述和荟萃分析定义和量化了机械通气开始的48小时内深度镇静产生的影响。主要结果是死亡率,次要终点包括住院和ICU的住院时间,机械通气时间,谵妄和气管切开发生的频率。此项检索的数据来源有MEDLINE、EMBASE、Scopus、Cochrane对照试验中心登记册,综述和效果的

越来越多的数据表明,早期的深度镇静可能会对临床结果产生一定的负面影响。

近期,一项发表在杂志Crit care med上的系统综述和荟萃分析定义和量化了机械通气开始的48小时内深度镇静产生的影响。主要结果是死亡率,次要终点包括住院和ICU的住院时间,机械通气时间,谵妄和气管切开发生的频率。

此项检索的数据来源有MEDLINE、EMBASE、Scopus、Cochrane对照试验中心登记册,综述和效果的摘要数据库,Cochrane系统评价数据库,ClinicalTrials.gov,会议记录和文献参考。纳入了随机对照试验和非随机研究。由两位评审员独立筛选已确定的研究摘要。

最终,共纳入2012年至2017年间发表的9项研究(n = 4,521例)。随机效应荟萃分析模型显示与深度镇静相比(27.6%),早期轻度镇静与较低的死亡率(9.2%)相关(优势比0.34 [0.21-0.54])。轻度镇静与机械通气(平均差,-2.1; 95%CI,-3.6〜-0.5)和ICU住院天数(平均差,-3.0(95%CI,-5.4〜-0.6))相关,谵妄发生率在轻度镇静组为28.7 %,深度镇静组为48.5%,比值比为0.50(0.22-1.16)。

此项研究结果表明:与少数合格的异质随机对照试验和观察性研究中一致,机械通气患者的深度镇静与死亡率和住院时间增加相关。针对早期镇静深度评估的干预措施应该从急诊科入住直至随后入住ICU,对这一问题的进一步研究调查有助于改善临床结果。

原始出处:
Stephens RJ, Dettmer MR, et al. Practice Patterns and Outcomes Associated With Early Sedation Depth in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis. Crit Care Med. 2017 Dec 8. doi: 10.1097/CCM.0000000000002885. 

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-21 zwjnj2

    好好好吧学习学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-19 wzb521zf

    一起学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-18 I see you

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-15 sunfeifeiyang

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=271256, encodeId=ec782e1256dd, content=好好好吧学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Thu Dec 21 17:49:22 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270476, encodeId=18232e0476da, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Tue Dec 19 06:14:57 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270329, encodeId=c4092e032981, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbp2rCaicYWQEk46A8KrHPEUOII3qyWvtWgSBn9X7kkiaCRoleayoBsgXpvDK01WvBVkJA1ZpjJP2Q/0, createdBy=9aba2224539, createdName=I see you, createdTime=Mon Dec 18 11:26:20 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608354, encodeId=00b81608354be, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 17 08:04:00 CST 2017, time=2017-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269675, encodeId=5d082696e5a3, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Dec 15 20:03:34 CST 2017, time=2017-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=269640, encodeId=c27b2696409d, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Dec 15 17:22:29 CST 2017, time=2017-12-15, status=1, ipAttribution=)]
    2017-12-15 131****1460

    学习了受益匪浅

    0

相关资讯

Chest:镇痛镇静的深度对使用机械通气的急诊患者预后的影响

镇痛和镇静是机械通气患者治疗中的基本手段。目前已经有数据显示对ICU患者进行早期深度镇静可影响患者预后,但在急诊科(ED)却没有对此进行过调查。因此,镇静镇痛的深度对急诊科患者预后的影响仍属未知。本研究的目的是为了明确如何对急诊患者实施镇静镇痛,以及镇静镇痛对急诊机械通气患者预后会产生不同影响这一假说进行验证。

Anesth Analg:监测声门下二氧化碳水平以优化机械通气患者气管导管套囊压力:随机对照试验

机械通气的许多并发症与气管插管(ETT)套囊压力不适当有关。 本研究的目的是评估长时间插管患者自动套囊压力闭环控制的有效性,其中声门下出现二氧化碳(CO2)作为泄漏指标。 研究的主要结果是使用CO2泄漏随时间曲线下的面积(AUC)量化的套囊周围渗漏量。

JAMA:长期机械通气镇静:右美托咪定优于咪达唑仑和丙泊酚

重症监护病房(ICU)的患者长期使用咪达唑仑或丙泊酚镇静会对患者产生严重的不良影响。右美托咪定是一种ICU镇静常用的α-2激动剂,可缩短机械通气时间,提高病人的舒适度。

Crit Care Med:长期机械通气患者接受姑息治疗和呼吸机撤离的决定因素

越来越多的长期机械通气患者在对医疗系统产生了巨大的压力的同时,他们自己的生活质量也极差。然而,目前却没有任何研究探讨接受姑息治疗或临终关怀患者的意愿及其影响因素。

Crit care med:无机械通气天数可能会误导临床医生的判断!

急性呼吸窘迫综合征患者常常需要有创机械通气,关于其死亡率和机械通气时间均为临床医生重视的结果。已经有学者提出,无需机械通气的天数概念作为上述两个结果的重要补充指标。近期,一项发表在杂志Crit care med上的研究分析了无需机械通气天数的结果,并提供了一个假想的场景以提醒医生,这样的结果可能会导致对临床误导性的解释。研究者们提出了无机械通气天数的曲线概念,并且通过分析发展,说明了如何根据死亡率

Crit Care Med:呼吸机械通气患者是否需要使用抗生素治疗?

近期,一项发表在杂志Crit Care Med上的研究旨在评估表现为吸入性细菌性肺炎或非细菌性吸入性肺炎症状的ICU昏迷患者中记录的细菌吸入性肺炎患者的比例。此项研究为前瞻性观察研究,选取250名昏迷(格拉斯哥昏迷量表评分≤8)并使用侵入性机械通气治疗的ICU患者。此项研究的主要结果是微生物学记录的细菌吸入性肺炎患者的比例。满足预期吸入综合征标准的患者在开始概率性抗生素治疗之前,常规地在支气管镜检